Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 2
2005 4
2006 5
2007 2
2008 4
2009 2
2010 2
2011 2
2012 6
2013 3
2014 5
2015 2
2016 4
2017 3
2018 7
2019 5
2020 9
2021 11
2022 11
2023 5
2024 8
2025 8
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

100 results

Results by year

Filters applied: . Clear all
Page 1
Type 2 diabetes remission after initiation of GLP-1 receptor agonists: frequency, characteristics, and outcomes using multiple definitions in an observational study.
Fadini GP, Giaccari A, Broglio F, Nollino L, Fattor B, Anichini R, Meregalli G, Avogaro A, Consoli A; GLIMPLES Study Investigators. Fadini GP, et al. Among authors: consoli a. Lancet Reg Health Eur. 2025 Oct 15;59:101499. doi: 10.1016/j.lanepe.2025.101499. eCollection 2025 Dec. Lancet Reg Health Eur. 2025. PMID: 41142657 Free PMC article.
Effectiveness of oral semaglutide versus empagliflozin for the management of type 2 diabetes. PIONEER-2 trial emulation with real-world data.
Fadini GP, Longato E, Poletto S, Giaccari A, Ghiani M, Strazzabosco M, Trombetta M, Penno G, Avogaro A, Solini A, Consoli A; GLIMPLES study investigators and DARWIN‐Renal study investigators. Fadini GP, et al. Among authors: consoli a. Diabetes Obes Metab. 2025 Dec;27(12):7431-7440. doi: 10.1111/dom.70151. Epub 2025 Sep 24. Diabetes Obes Metab. 2025. PMID: 40990044 Free PMC article.
Interleukin-1β in circulating mononuclear cells predicts steatotic liver disease improvement after weight loss in subjects with obesity and prediabetes or type 2 diabetes.
Simeone PG, Costantino S, Liani R, Tripaldi R, Di Castelnuovo A, Tartaro A, Mengozzi A, Cosentino F, Cipollone F, Consoli A, Paneni F, Santilli F. Simeone PG, et al. Among authors: consoli a. Cardiovasc Diabetol. 2025 Jun 13;24(1):247. doi: 10.1186/s12933-025-02706-8. Cardiovasc Diabetol. 2025. PMID: 40514652 Free PMC article. Clinical Trial.
Comparative renal outcomes of matched cohorts of patients with type 2 diabetes receiving SGLT2 inhibitors or GLP-1 receptor agonists under routine care.
Fadini GP, Longato E, Morieri ML, Bonora E, Consoli A, Fattor B, Rigato M, Turchi F, Del Prato S, Avogaro A, Solini A; DARWIN-Renal Study Investigators. Fadini GP, et al. Among authors: consoli a. Diabetologia. 2024 Nov;67(11):2585-2597. doi: 10.1007/s00125-024-06251-z. Epub 2024 Aug 23. Diabetologia. 2024. PMID: 39177691 Free PMC article.
100 results